Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies
Cancer cells proliferate and invade via cytoskeletal proteins such as WASp, exclusively expressed in hematopoietic cells. Here the authors show a specific small molecule compound inhibiting cancer cell activity by WASp degradation and demonstrating its therapeutic potential in vitro and in vivo.
Guardado en:
Autores principales: | Guy Biber, Aviad Ben-Shmuel, Elad Noy, Noah Joseph, Abhishek Puthenveetil, Neria Reiss, Omer Levy, Itay Lazar, Ariel Feiglin, Yanay Ofran, Meirav Kedmi, Abraham Avigdor, Sophia Fried, Mira Barda-Saad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/42c120d99789446b99e08ed0d9914e76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cells
por: Yoav Elkis, et al.
Publicado: (2017) -
Large scale analysis of phenotype-pathway relationships based on GWAS results.
por: Aharon Brodie, et al.
Publicado: (2014) -
Theory of nucleation
por: Baranov, Serghei
Publicado: (2006) -
Comparison of classical nucleation theory and modern theory of phase transition in the case of electrochemical nucleation
por: Baranov, Serghei
Publicado: (2016) -
Biomechanical Evaluation of Wasp and Honeybee Stingers
por: Rakesh Das, et al.
Publicado: (2018)